HtrA Inhibitors and CagA Inhibitors and Use Thereof
申请人:PSOMAGEN INC.
公开号:US20220122691A1
公开(公告)日:2022-04-21
The present application relates to new HtrA inhibitors and use thereof. Additionally, the present application also relates to new peptides for inhibiting CagA and use thereof.